Delivery Order SPE2DR25D3303-SPE2DR26F63F9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,899.60 to AmerisourceBergen Drug Corp for Methenamine Hippurate 1 GM tablets (100-count packages) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,882.35 for Methenamine Hippurate 1 gram tablets (100-count) with a completion date of December 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,589.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Methenamine Hippurate 1 gram tablets (100 count). The contract is set to be completed by October 24, 2025, and represents a non-set-aside competitive award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite...
- This federal contract award, identified as SPE2DB25D3005|SPE2DB25FQCCV, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,543.71, is for the delivery of Methenamine Hipp 1 GM Tablet 100S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred sixty-two dollars and twelve cents to Amerisourcebergen Drug Corporation for 4562146235 methamine hipp 1 gm tablets. The order is for one hundred tablets to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 13, 2023. The Defense Logistics Agency is a combat support agency under the Department of Defense responsible for worldwide logistics support. This order is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on November 10, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $6,036.44. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of November 12, 2025. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,929.09 for 100 capsules of Macrobid 100 mg, an antibiotic medication commonly used to treat urinary tract infections. The contract was awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, and employs firm fixed pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $76,399.62 for MYRBETRIQ ER 50 MG tablets (90-count supply) on October 17, 2025, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Phenazopyridine 200 mg tablets (100 count) under a firm fixed-price contract valued at $2,463.42, with an ultimate completion date of August 7, 2025. This non-set-aside award was issued on August 6, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methazolamide 50 mg tablets (100-count units) with a contract value of $4,031.07. This competitively awarded, non-set-aside delivery order is classified as a firm fixed-price contract with an ultimate completion date of August 7, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F63F9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,183.16 to AmerisourceBergen Drug Corp for Methenamine Hippurate 1 GM tablets (100-count) on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle extending through December 2026 that serves as the primary global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting presence as a critical supplier of medications and medical supplies to military and veteran healthcare systems. The company's portfolio encompasses a comprehensive range of pharmaceutical products across multiple therapeutic domains, with consistent delivery order awards through competitive procurement processes. This particular award for Methenamine Hippurate, an antibiotic commonly used to treat urinary tract infections, exemplifies the vendor's role in supplying essential medications to support Defense Health Agency operations and broader military medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 12/8/25 |